thalidomide has been researched along with Penile Diseases in 4 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Penile Diseases: Pathological processes involving the PENIS or its component tissues.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hu, YQ | 1 |
Yao, XX | 1 |
Zhang, JZ | 1 |
Li, WH | 1 |
Kim, TH | 1 |
Oh, SY | 1 |
Myung, SC | 1 |
Petropoulou, H | 1 |
Kontochristopoulos, G | 1 |
Kalogirou, O | 1 |
Panteri, I | 1 |
Zakopoulou, N | 1 |
Farrell, AM | 1 |
Black, MM | 1 |
Bracka, A | 1 |
Bunker, CB | 1 |
1 review available for thalidomide and Penile Diseases
Article | Year |
---|---|
Pyoderma gangrenosum of the penis.
Topics: Adult; Anti-Inflammatory Agents; Antitrichomonal Agents; Combined Modality Therapy; Drug Therapy, Co | 1998 |
3 other studies available for thalidomide and Penile Diseases
Article | Year |
---|---|
Penile pyoderma gangrenosum: Successful treatment with thalidomide.
Topics: Adolescent; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male | 2019 |
Pyoderma gangranosum of the penis.
Topics: Anti-Inflammatory Agents; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Penile Diseas | 2009 |
Effective treatment of erosive lichen planus with thalidomide and topical tacrolimus.
Topics: Administration, Topical; Humans; Immunosuppressive Agents; Lichen Planus; Lichen Planus, Oral; Male; | 2006 |